• Medical_Professionals
• Medical_students
• Nurses

The Australasian HIV&AIDS Conference (27th Annual Conference of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine) is the premier HIV Conference in Australia and the Asia and Pacific region.

The annual conference is run by ASHM as a platform for the dissemination and presentation of new and innovative research findings across the Australasian HIV sector.

Delegates to the conference come from a range of professional backgrounds including basic science, clinical medicine, community programs, education, epidemiology, indigenous health, international and regional issues, nursing and allied health, policy, primary care, public health and prevention, and social research.

The 2017 conference will focus on issues including but not limited to:

1. The National Strategies

2. Managing STIs in the era of biomedical prevention

3. Self-testing

4. The meaning of safe sex

5. HTLV-1

6. Aboriginal and Torres Strait Islander Health

7. Vaccines

8. Dual Therapy

9. Transgender health

10. Equity and access

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Avenue Hotel, Canberra

80 Northbourne Avenue

Canberra ACT 2602

These special conference accommodation rates have been negotiated for delegates and were only available when booked through the online registration system before the deadline 24 September 2017.

If you need to make changes to your booking after 24 September, please contact the hotel directly.

Submission Info

Theme A  The new research programmed to be presented at the ASHM conference will highlight strategies to prevent new infections and provide long term remission that will reduce the financial and complience cost of lifelong therapy. The basic science presentations in Track A include new research on HIV vaccines from Dr. Genoveffa Franchini who has worked on HIV and HTLV-1 in the National Institutes of Health laboratory where these viruses were discovered in the early 1980s. She will provide perspective build on new HIV vaccine concepts in non-human primates build on decades of work.  She will also present an understanding of how genetic variations in the Australian strains of HTLV-1 might impact on transmission and disease. Progress in basic science towards an HIV cure will be presented by Dr. Rowena Johnston who is research director for the AmFAR.  Research from our region highlights insights into the location, measurement and structure of the HIV reservoir that persists during effective cART. In addition new insights into how to generate antibodies that neutralise and prevent cell-cell transmission of HIV will be presented in the basic science sessions.  HIV basic research presented at the conference provides tangible progress and hope for solving the remaining vexing obstacles preventing the eradication of HIV. 

Theme B programming includes many key presentations to help clinicians look after their patients better; to guide PLHIV on how treatment changes will affect their lived experience and has implications for further HIV related research.  A snapshot of what will be covered includes:

Co-morbidities, toxicities growing old with HIV in Australia and the region

Optimising care – quality of life, quality of therapy and quality of guidelines

“If all I have is a hammer” – when to change the antiretrovirals versus when to add drugs to treat osteoporosis and other morbidities

Theme C will cover the latest research on the epidemiology and prevention of HIV, including: 

Understanding gaps in access and inequity in the prevention response and initiatives to address these gaps

Implementation and behavioural research on PrEP in Australia and overseas

Treatment as prevention - how can it be optimized?

Tracking progress to elimination - how do we do it?

Theme D will cover:

How priority populations and other communities are making sense of and adapting to the increasing role of biomedical technologies within combination prevention

Why thinking meaningfully about diverse experiences of gender and sexuality can strengthen both effectiveness and inclusiveness in HIV prevention, services and research

What we can learn from those communities whose health is put at risk by criminalisation and other punitive policy frameworks

Where and why HIV policy can be extended to encompass the distinctive needs and preferences of minority groups  

Abstract submission deadline 2018-06-02

Access and Engage healthcare professionals working in HIV and/or Sexual health and related diseases both face-to-face and over a nine month period

Create Awareness and Understanding for your brand and organisation with an opportunity to showcase your latest product developments and updates in new technologies that differentiate you from your competitors

Build and Improve Relationships with current and potential clients throughout the Conference program and continue to build your reputation as a leader in the field

Enhance Your Credibility and Corporate Social Responsibility by participating in the Conference run by the peak body for healthcare professionals in HIV and/or Sexual Health and related diseases sector in Australasia.

The following prospectus’ will demonstrate how to make your organisation top of mind with Australasian and International healthcare professionals in the HIV and/or Sexual Health and related diseases sector.

To find out more about the excellent Sponsorship & Exhibition opportunities available at the conference, please contact:

HIV&AIDS Supporter Enquiries

Amanda Burg

T: +61 2 8204 0775

E: info@hivaidsconference.com.au

Australasian HIV & AIDS Conference Secretariat

ASHM Conference & Events Division

LMB 5057, Darlinghurst, NSW 2010

T: +61 2 8204 0770

F: +61 2 8204 0782

E: info@hivaidsconference.com.au